|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted cash | |||||||||
| Investment securities | |||||||||
| Accounts receivable, net of allowance of $5,284 at June 30, 2026 and $6,170 at December 31, 2025 | |||||||||
| Income tax receivable | |||||||||
| Prepaid expenses | |||||||||
| Other current assets | |||||||||
| Total current assets | |||||||||
| Property, plant and equipment, net | |||||||||
| Operating lease right-of-use assets, net | |||||||||
| Intangible assets, net | |||||||||
| Goodwill | |||||||||
| Deferred costs | |||||||||
| Other long-term assets | |||||||||
| Total assets | |||||||||
| Liabilities and stockholders’ equity | |||||||||
| Current liabilities | |||||||||
| Accounts payable | |||||||||
| Accrued compensation | |||||||||
| Aggregated funds payable | |||||||||
| Other accrued expenses | |||||||||
| Deferred revenue | |||||||||
| Current portion of long-term debt | |||||||||
| Nonrelated Party | |||||||||
| Related Party | |||||||||
| Total current portion of long-term debt | |||||||||
| Current portion of operating lease liabilities | |||||||||
| Current portion of finance lease liabilities | |||||||||
| Total current liabilities | |||||||||
| Long-term liabilities | |||||||||
| Deferred tax liability | |||||||||
| Long-term debt, net, less current portion | |||||||||
| Nonrelated Party | |||||||||
| Related Party | |||||||||
| Total long-term debt, net, less current portion | |||||||||
| Operating lease liabilities, net of current portion | |||||||||
| Finance lease liabilities, net of current portion | |||||||||
| Deferred revenue - long-term | |||||||||
| Other long-term liabilities | |||||||||
| Total liabilities | |||||||||
| Stockholders’ equity | |||||||||
| Preferred stock $0.01 par value - 100,000,000 and zero shares authorized as of March 31, 2026 and December 31, 2025, respectively; zero shares issued or outstanding as of March 31, 2026 and December 31, 2025, respectively | |||||||||
| Common stock $0.01 par value - 2,500,000,000 and 227,000,000 shares authorized at March 31, 2026 and December 31, 2025, respectively; 191,685,290 and 191,587,193 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | |||||||||
| Treasury stock, at cost | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated other comprehensive income (loss) | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders’ equity | |||||||||
| Total liabilities and stockholders’ equity |
Loading...
